SMED · Sharps Compliance Corp - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | Q3 '22 | Q2 '22 | Q1 '22 | Q2 '21 | Q3 '21 | Q1 '21 | Q2 '20 | Q3 '20 | Q1 '20 | Q2 '19 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $17.58M | $18.88M | $13.91M | $17.01M | $27.53M | $13.15M | $14.56M | $10.41M | - | - |
| Cost of Revenue | $12.60M | $12.27M | $10.49M | $11.37M | $14.13M | $9.53M | $9.69M | $8.19M | $9.12M | $7.99M |
| Gross Profit | $4.98M | $6.61M | $3.42M | $5.64M | $13.40M | $3.62M | $4.87M | $2.22M | $4.48M | $3.99M |
| R&D | - | - | - | - | - | - | - | - | - | - |
| SG&A | $4.71M | $4.39M | $4.20M | $3.76M | $4.18M | $3.79M | $3.61M | $3.60M | $3.51M | $2.96M |
| Total Operating Expenses | - | - | - | - | - | - | - | - | - | - |
| D&A | $272.0K | $236.0K | $582.0K | $205.0K | $216.0K | $423.0K | $197.0K | $201.0K | $421.0K | $205.0K |
| Operating Income | ($7.0K) | $1.98M | ($997.0K) | $1.68M | $9.00M | ($369.0K) | $1.07M | ($1.58M) | $768.0K | $827.0K |
| Interest Expense | $53.0K | $58.0K | $56.0K | $47.0K | $55.0K | $32.0K | $26.0K | $36.0K | $19.0K | $23.0K |
| Income Tax | $287.0K | $529.0K | - | $411.0K | $2.12M | ($103.0K) | $77.0K | ($54.0K) | $68.0K | $33.0K |
| Net Income | ($287.0K) | $1.44M | ($790.0K) | $1.23M | $6.85M | ($293.0K) | $970.0K | ($1.56M) | $686.0K | $779.0K |
| EPS - Basic | ($0.01) | $0.07 | ($0.02) | - | ($0.10) | - | - | - | - | - |
| EPS - Diluted | ($0.01) | $0.07 | ($0.02) | - | ($0.10) | - | - | - | - | - |
Balance Sheet
| Line item | Q3 '22 | Q2 '22 | Q1 '22 | Q2 '21 | Q3 '21 | Q1 '21 | Q2 '20 | Q3 '20 | Q1 '20 | Q2 '19 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $26.74M | $36.00M | $41.16M | $27.77M | $11.22M | $6.79M | $5.42M | $4.90M | $4.87M | $4.51M |
| Accounts Receivable | $14.79M | $13.05M | $9.85M | $9.74M | $23.41M | $10.63M | $11.79M | $9.56M | $10.69M | $9.29M |
| Inventory | $6.98M | $6.82M | $7.27M | $6.11M | $4.38M | $5.48M | $5.64M | $4.91M | $3.28M | $3.77M |
| Accounts Payable | $3.09M | $3.59M | $2.97M | $2.92M | $3.55M | $3.14M | $3.29M | $3.25M | $2.51M | $2.95M |
| Current Assets | $51.98M | $57.74M | $60.06M | $45.10M | $39.49M | $23.91M | $24.29M | $21.04M | $19.96M | $18.75M |
| Total Assets | $93.34M | $90.83M | $89.78M | $75.43M | $69.72M | $55.57M | $54.14M | $48.24M | $45.95M | $36.04M |
| Current Liabilities | $14.85M | $14.99M | $15.72M | $17.15M | $18.82M | $13.77M | $13.24M | $11.36M | $10.05M | $8.18M |
| Long-term Debt | $3.10M | $3.17M | $3.24M | $3.33M | $3.62M | $3.43M | $3.50M | $1.75M | $1.07M | $948.0K |
| Total Liabilities | $28.92M | $26.20M | $26.94M | $28.85M | $30.90M | $25.90M | $24.56M | $21.07M | $19.00M | $9.91M |
| Stockholders' Equity | $64.41M | $64.63M | $62.84M | $46.58M | $38.82M | $29.67M | $29.58M | $27.17M | $26.94M | $26.13M |
| Retained Earnings | $12.58M | $14.28M | $12.84M | $13.63M | $8.55M | $468.0K | $761.0K | ($1.41M) | ($819.0K) | ($1.50M) |
Cash Flow
| Line item | Q3 '22 | Q2 '22 | Q1 '22 | Q2 '21 | Q3 '21 | Q1 '21 | Q2 '20 | Q3 '20 | Q1 '20 | Q2 '19 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | ($3.05M) | - | - | $1.76M | - | - | $817.0K | - |
| Investing Cash Flow | - | - | ($65.0K) | - | - | ($973.0K) | - | - | ($622.0K) | - |
| Financing Cash Flow | - | - | $16.51M | - | - | $581.0K | - | - | $159.0K | - |
| CapEx | - | - | $47.0K | - | - | $925.0K | - | - | $604.0K | - |
| Free Cash Flow | - | - | ($3.10M) | - | - | $836.0K | - | - | $213.0K | - |
Ratios
| Metric | Q3 '22 | Q2 '22 | Q1 '22 | Q2 '21 | Q3 '21 | Q1 '21 | Q2 '20 | Q3 '20 | Q1 '20 | Q2 '19 |
|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||||
| Gross margin | 28.3% | 35.0% | 24.6% | 33.1% | 48.7% | 27.5% | 33.5% | 21.3% | - | - |
| Operating margin | -0.0% | 10.5% | -7.2% | 9.9% | 32.7% | -2.8% | 7.3% | -15.2% | - | - |
| EBITDA margin | 1.5% | 11.8% | -3.0% | 11.1% | 33.5% | 0.4% | 8.7% | -13.2% | - | - |
| Net margin | -1.6% | 7.6% | -5.7% | 7.2% | 24.9% | -2.2% | 6.7% | -14.9% | - | - |
| Free cash flow margin | - | - | -22.3% | - | - | 6.4% | - | - | - | - |
| FCF / Net income | - | - | 3.92 | - | - | -2.85 | - | - | 0.31 | - |
| R&D / Revenue | - | - | - | - | - | - | - | - | - | - |
| SG&A / Revenue | 26.8% | 23.2% | 30.2% | 22.1% | 15.2% | 28.8% | 24.8% | 34.6% | - | - |
| Effective tax rate | - | 26.9% | - | 25.1% | 23.7% | - | 7.4% | - | 9.0% | 4.1% |
| Return on assets | -0.3% | 1.6% | -0.9% | 1.6% | 9.8% | -0.5% | 1.8% | -3.2% | 1.5% | 2.2% |
| Return on equity | -0.4% | 2.2% | -1.3% | 2.6% | 17.6% | -1.0% | 3.3% | -5.7% | 2.5% | 3.0% |
| Return on invested capital | -0.0% | 2.1% | - | 2.5% | 16.2% | -0.9% | 3.0% | -4.3% | 2.5% | 2.9% |
| Liquidity | ||||||||||
| Current ratio | 3.50 | 3.85 | 3.82 | 2.63 | 2.10 | 1.74 | 1.83 | 1.85 | 1.99 | 2.29 |
| Quick ratio | 3.03 | 3.40 | 3.36 | 2.27 | 1.87 | 1.34 | 1.41 | 1.42 | 1.66 | 1.83 |
| Cash ratio | 1.80 | 2.40 | 2.62 | 1.62 | 0.60 | 0.49 | 0.41 | 0.43 | 0.48 | 0.55 |
| Leverage | ||||||||||
| Debt / Equity | 0.05 | 0.05 | 0.05 | 0.07 | 0.09 | 0.12 | 0.12 | 0.06 | 0.04 | 0.04 |
| Debt / Assets | 0.03 | 0.03 | 0.04 | 0.04 | 0.05 | 0.06 | 0.06 | 0.04 | 0.02 | 0.03 |
| Debt / EBITDA | 11.68 | 1.43 | - | 1.77 | 0.39 | 63.48 | 2.77 | - | 0.90 | 0.92 |
| Interest coverage | -0.1x | 34.2x | -17.8x | 35.7x | 163.7x | -11.5x | 41.1x | -43.8x | 40.4x | 36.0x |
| Equity multiplier | 1.45 | 1.41 | 1.43 | 1.62 | 1.80 | 1.87 | 1.83 | 1.78 | 1.71 | 1.38 |
| Liabilities / Assets | 0.31 | 0.29 | 0.30 | 0.38 | 0.44 | 0.47 | 0.45 | 0.44 | 0.41 | 0.28 |
| Efficiency | ||||||||||
| Asset turnover | 0.19 | 0.21 | 0.15 | 0.23 | 0.39 | 0.24 | 0.27 | 0.22 | - | - |
| Inventory turnover | 1.81 | 1.80 | 1.44 | 1.86 | 3.23 | 1.74 | 1.72 | 1.67 | 2.78 | 2.12 |
| Days sales outstanding | 307d | 252d | 258d | 209d | 310d | 295d | 295d | 335d | - | - |
| Days inventory outstanding | 202d | 203d | 253d | 196d | 113d | 210d | 212d | 219d | 131d | 172d |
| Days payable outstanding | 90d | 107d | 103d | 94d | 92d | 120d | 124d | 145d | 101d | 135d |
| Cash conversion cycle | 420d | 348d | 408d | 311d | 332d | 384d | 384d | 409d | - | - |
| Valuation | ||||||||||
| P / E | - | - | - | - | - | - | - | - | - | - |
| P / B | - | - | - | - | - | - | - | - | - | - |
| P / S | - | - | - | - | - | - | - | - | - | - |
| EV / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Growth | ||||||||||
| Revenue growth (YoY) | -36.1% | 11.0% | 5.8% | 16.8% | 164.3% | - | - | - | - | - |
| Revenue CAGR (3y) | - | - | - | 15.2% | 42.9% | 10.7% | 14.5% | 6.6% | - | - |
| Revenue CAGR (5y) | 15.4% | 14.2% | 7.9% | 11.2% | 32.9% | 10.8% | 10.9% | 11.0% | - | - |
| Gross profit growth (YoY) | -62.8% | 17.2% | -5.6% | 15.7% | 502.7% | -19.2% | 22.1% | 9.2% | 33.8% | 27.5% |
| Operating income growth (YoY) | - | 18.3% | -170.2% | 56.8% | - | - | 29.3% | -47.1% | 514.4% | 672.9% |
| Net income growth (YoY) | - | 17.0% | -169.6% | 26.6% | - | - | 24.5% | -38.3% | 880.0% | 399.4% |
| EPS growth (YoY) | 90.0% | - | - | - | - | - | - | - | - | - |
| EPS CAGR (3y) | - | - | - | - | - | - | - | - | - | - |
| EPS CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| FCF growth (YoY) | - | - | - | - | - | 292.5% | - | - | -30.6% | - |
| FCF CAGR (5y) | - | - | - | - | - | -6.4% | - | - | 14.3% | - |
| Book value growth (YoY) | 65.9% | 38.7% | 111.8% | 57.5% | 42.9% | 10.1% | 13.2% | 6.4% | 4.9% | 3.8% |
Sales by segment
From XBRL dimensional facts in the 10-K period ending 2021-06-30.
Product / service
$76.42M totalMailbacks$49.62M · 64.9%
Route Based Pickup Services$13.68M · 17.9%
Unused Medications$8.16M · 10.7%
Product And Service Other$4.40M · 5.8%
Third Party Treatment Services$570.0K · 0.7%
Peer comparison
Same SIC group: Hazardous Waste Management
Comparing SHARPS COMPLIANCE CORP against the 5 most active filers in the same SIC group.